Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Terminated 7 Withdrawn 6 Recruiting 4 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 224 Cyclophosphamide 192 Radiotherapy 183 Nivolumab 180 Carboplatin 153 Cisplatin 114 Paclitaxel 112 Dexamethasone 110 Radiosurgery 104 Magnetic Resonance Spectroscopy 97 Surveys and Questionnaires 91 Ipilimumab 81 Doxorubicin 79 Lenalidomide 76 durvalumab 75 Rituximab 75 atezolizumab 72 Radiation 72 venetoclax 69 fludarabine 68 Standard of Care 68 Gemcitabine 68 Specimen Handling 65 Etoposide 64 Capecitabine 64 Bevacizumab 62 Oxaliplatin 59 Docetaxel 58 Biopsy 58 Radiotherapy, Intensity-Modulated 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × Ferrosoferric Oxide × Clear all

NCT04900792 2025-12-03

XACT-Fe-GBM-01

University of Iowa

Phase 1 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡